USPatentGranted
E1

Process for the synthesis of agomelatine

Granted 29 Nov 2016 · 2 office actions

Current assignee: Les Laboratoires Servier · originally Servier Laboratories

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Béatrice Sire, Samir Zard, Mehdi Boumediene · Examiner: Gary Kunz · AU 3991 · TC 3900

Application
14/619,284
filed 4 Jan 2012
Publication
Not published
not published
Patent· this page
US RE46218
granted 29 Nov 2016

Life of the patent

2 dated events
⤢ drag to zoomJan 2012Jul 2012Jan 2013Jul 2013Jan 2014Jul 2014Jan 2015Jul 2015Jan 2016Jul 2016Jan 2017Prosecution
Prosecutionhover for detail · click to open

Abstract

Process for the industrial synthesis of the compound of formula (I) [structure]

Description

12 parts
›This application is a 371 of PCT/FR12/00005, filed…

This application is a 371 of PCT/FR12/00005, filed Jan. 4, 2012.

The present invention relates to a new process for the industrial synthesis of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, of formula (I):

Agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, has valuable pharmacological properties.

It has, in fact, the double characteristic of being, on the one hand, an agonist of receptors of the melatoninergic system and, on the other hand, an antagonist of the 5-HT 2C receptor. These properties provide it with activity in the central nervous system and, more especially, in the treatment of major depression, seasonal affective disorder, sleep disorders, cardiovascular pathologies, pathologies of the digestive system, insomnia and fatigue due to jet-lag, appetite disorders and obesity.

Agomelatine, its preparation and its use in therapeutics have been described in European patent specifications EP 0 447 285 and EP 1 564 202.

In view of the pharmaceutical value of this compound, it has been important to be able to produce it using an effective industrial synthesis process which is readily transferable to the industrial scale and which provides agomelatine in a good yield and with excellent purity.

Patent specification EP 0 447 285 describes production of agomelatine in eight steps starting from 7-methoxy-1-tetralone.

In patent specification EP 1 564 202, the Applicant developed a new, much more effective and industrialisable synthesis route in only four steps starting from 7-methoxy-1-tetralone that makes it possible to obtain agomelatine in highly reproducible manner in a well-defined crystalline form.

However, the search for new synthesis routes, especially starting from starting materials that are less costly than 7-methoxy-1-tetralone, is currently still relevant.

The Applicant has continued his investigations and has developed a new process for the synthesis of agomelatine starting from allyl cyanide and a xanthate compound: these new starting materials have the advantage of being simple and readily obtainable in large quantities at less cost.

This synthesis route is based on carrying out free radical reactions that are not very commonly used but are nevertheless very effective. Converting these reactions to the industrial scale using continuous-flow reactors is promising as it becomes simpler to control propagation of the chain reaction.

This new process moreover makes it possible to obtain agomelatine in reproducible manner and without requiring laborious purification, with a purity that is compatible with its use as a pharmaceutical active ingredient. Indeed, agomelatine can accordingly be synthesised in 6 steps in the course of which only two of the intermediates are isolated.

More specifically, the present invention relates to a process for the industrial synthesis of the compound of formula (I):

which process is characterised in that allyl cyanide of formula (II):

is reacted, in the presence of a free radical initiator, with a compound of formula (III):

wherein Xa represents a group —S—C(S)—OR in which R represents a linear or branched (C 1 -C 6 )alkyl group,

to yield the compound of formula (IV):

wherein Xa is as defined hereinbefore,

it being possible for this latter compound optionally to be isolated, before being subjected to a cyclisation reaction in the presence of a free radical initiator in order to form the compound of formula (V):

which compound of formula (V) also optionally may be isolated,

which is subjected to a reduction-dehydration reaction to yield the compound of formula (VI):

which is then subjected to an aromatisation reaction to yield the compound of formula (VII):

which is subjected to reduction using hydrogen in the presence of Raney nickel in a polar protic medium and to reaction with acetic anhydride to yield the compound of formula (I), which is isolated in the form of a solid.

In a preferred embodiment of the invention, the compound of formula (VII) is then subjected to reduction using hydrogen in the presence of Raney nickel in an ammoniacal ethanol medium and then converted into a salt using hydrochloric acid to yield the compound of formula (VIII):

which is successively subjected to the action of sodium acetate and then acetic anhydride to yield the compound of formula (I), which is isolated in the form of a solid.

Alternatively, the compound of formula (VII) can be subjected to reduction by hydrogen in the presence of Raney nickel in a medium comprising acetic anhydride in a polar protic medium to yield the compound of formula (I), which is isolated in the form of a solid.

In a preferred compound of formula (III), Xa represents a group —S—C(S)—OC 2 H 5 .

In the processes according to the invention, initiation of the free radical reactions is carried out by thermal means. Preferably, the reaction mixture is heated to a temperature of from 50° C. to 140° C. Even more preferably, cyclisation is carried out at a temperature of from 130 to 135° C.

Peroxides are free radical initiators that are especially suitable for carrying out the step of addition of the compound of formula (II) to the compound of formula (III), or for performing cyclisation of the compound of formula (IV) to form the compound of formula (V). By way of example, there may be mentioned, especially, diisobutyryl peroxide, cumyl peroxyneodecanoate, tert-amyl peroxyneodecanoate, di(2-ethylhexyl)peroxydicarbonate, tert-butyl peroxyneodecanoate, dibutyl peroxydicarbonate, dicetyl peroxydicarbonate, dimyristyl peroxydicarbonate, tert-butyl peroxyneoheptanoate, tert-amyl peroxypivalate, didecanoyl peroxide, tert-amyl peroxy-2-ethylhexanoate, tert-butyl peroxyisobutyrate, 1,4-di(tert-butylperoxycarbo)cyclohexane, tert-butyl peroxyacetate, tert-butyl peroxybenzoate, di-tert-amyl peroxide, tert-butyl cumyl peroxide, bis(tert-butyl)peroxide, dicumyl peroxide, dilauroyl peroxide (DLP) or di(4-tert-butylcyclohexyl)peroxydicarbonate.

Preferably, the reaction is initiated in the presence of dilauroyl peroxide.

›The amount of dilauroyl peroxide used in the…

The amount of dilauroyl peroxide used in the cyclisation is preferably from 1 to 2.5 equivalents.

In a preferred embodiment of the invention, dilauroyl peroxide is added to the medium in stages.

The addition and/or cyclisation reactions are carried out in a solvent customarily used in free radical chemistry such as 1,2-dichloroethane, dichloromethane, benzene, toluene, trifluoromethylbenzene, chlorobenzene, hexane, cyclohexane, heptane, octane, ethyl acetate, tert-butyl alcohol, and mixtures thereof.

Preference is given to using ethyl acetate in the step of addition of the compound of formula (II) to the compound of formula (III), whilst cyclisation of the compound of formula (IV) to form the compound of formula (V) is advantageously carried out in chlorobenzene, ethyl acetate or ethyl butyrate. In this latter reaction, chlorobenzene is more especially preferred.

Conversion of the compound of formula (V) into the compound of formula (VI) is advantageously carried out in the presence of a Lewis acid such as aluminium isopropoxide or samarium isopropoxide. This conversion is moreover preferably carried out in an alcohol (primary or secondary), and even more preferably in isopropanol.

Preferably, a catalytic amount of p-toluenesulphonic acid is added to the mixture once all the tetralone (V) has been consumed at the end of conversion of the compound of formula (V) into the compound of formula (VI).

Aromatisation of compound (VI) is carried out in the presence of a quinone, preferably in the presence of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) or tetrachlorobenzoquinone (TCQ). Even more preferably, aromatisation is carried out in the presence of TCQ at the reflux of toluene.

The compound of formula (II) is accessible to the person skilled in the art by means of conventional chemical reactions and/or chemical reactions described in the literature.

This process is especially valuable for the following reasons:

it makes it possible to obtain the compound of formula (I) on an industrial scale in good yields, starting from a simple, low-cost starting material; only the intermediates of formulae (VI) and (VII) require a purification and isolation step.

The compounds of formulae (V) and (VI) obtained according to the process of the invention are new and useful as intermediates in the synthesis of agomelatine.

The Examples hereinbelow illustrate the invention without limiting it in any way. For the purpose of validating the reaction route, the synthesis intermediates were systematically isolated and characterised. However, it is possible to considerably optimise the procedures by limiting the number of intermediates isolated. Accordingly, Example 2 given hereinbelow corresponds to the same reaction route as that used in Example 1 but with the difference that only (7-methoxy-1,2-dihydro-1-naphthyl)acetonitrile and (7-methoxy-1-naphthyl)acetonitrile were isolated.

›EXAMPLE 1

N-[2-(7-Methoxy-1-naphthyl)ethyl]acetamide

›Step A: S-[1-(cyanomethyl)-4-(4-methoxyphenyl)-4-oxobutyl]-O-ethyl dithiocarbonate

A solution of allyl cyanide (4.8 mL, 60.0 mmol) and S-[2-(4-methoxyphenyl)-2-oxoethyl]-O-ethyl dithiocarbonate 1 (8.1 g, 30.0 mmol) in ethyl acetate (30 mL) is heated at reflux for 15 minutes under a nitrogen atmosphere. There is added, firstly, an amount of dilauroyl peroxide (10 mol %) to the solution under reflux. After 1 hour 30 minutes, another amount of dilauroyl peroxide (5 mol %) is also introduced. When the reagents have been completely consumed, the mixture is cooled to ambient temperature and concentrated under reduced pressure. The crude mixture is then purified by flash column chromatography (petroleum ether-ethyl acetate: 95-5 to 80-20) to yield the title compound in the form of an oil in a yield of 98%. 1 S-[2-(4-methoxyphenyl)-2-oxoethyl]-O-ethyl dithiocarbonate is obtained according to the protocol described in Batanero, B. et al., J. Org. Chem. 2001, 66, 320.

1 H NMR (δ, ppm) 7.93 (m, 2H, CH-4), 6.93 (m, 2H, CH-3), 4.67-4.57 (m, 2H, CH 2 -13), (CDCl 3 , 400 MHz) 3.99 (m, 1H, CH-9), 3.87 (s, 3H, CH 3 -1), 3.15 (t, 2H, J=7.3 Hz, CH 2 -7), 2.95 (dd, 2H, J=17.0, 6.0 Hz, CH 2 -10), 2.41-2.31 (m, 1H, CH 2 -8), 2.19-2.08 (m, 1H, CH 2 -8), 1.41 (t, 3H, J=7.1 Hz, CH 3 -14).

›Step B: (7-Methoxy-4-oxo-1,2,3,4-tetrahydro-1-naphthyl)acetonitrile

The compound of Step A, used directly without having been purified, is redissolved in chlorobenzene (900 mL) and the solution is refluxed for 15 minutes under a nitrogen atmosphere. Dilauroyl peroxide is then gradually added to the solution under reflux (10 mol % every 10 minutes). When the reaction is complete, the mixture is cooled to ambient temperature and concentrated under reduced pressure. Acetonitrile is then introduced in order to cause a large part of the dilauroyl peroxide compounds to precipitate out. The mixture is then filtered, concentrated under reduced pressure and purified by flash column chromatography (petroleum ether-ethyl acetate: 60-40) to yield the title compound in solid form in a yield of 40%.

HRMS (EI, m/z) Calc. for C 13 H 13 NO 2 : 215.0946; found: 215.0946.

›Step C: (7-Methoxy-1,2-dihydro-1-naphthyl)acetonitrile

Aluminium isopropoxide (2.05 g, 10.0 mmol) is added to a solution of the compound obtained in Step B (680 mg, 3.15 mmol) in isopropanol (15 mL) at ambient temperature. The reaction mixture is refluxed. When the reagents have been completely consumed, a few crystals of p-toluenesulphonic acid monohydrate are added and a Dean-Stark apparatus is mounted on top of the flask. The mixture is again refluxed for 1 hour, during which the isopropanol is gradually replaced with toluene by means of the Dean-Stark apparatus. A 1N HCl solution is then added and the resulting phases are separated. The aqueous phase is extracted with ethyl acetate, the organic phases being washed with saturated NaHCO 3 solution and with saturated NaCl solution, then dried over MgSO 4 , filtered and concentrated under reduced pressure. The residue is purified by column chromatography (petroleum ether-ethyl acetate: 80-20) to yield the title product in the form of an oil in a yield of 85%.

HRMS (EI, m/z) Calc. for C 13 H 13 NO: 199.0997. found: 199.1001.

›Step D: (7-Methoxy-1-naphthyl)acetonitrile

Method A:

To a solution of the compound obtained in Step C (1.0 g, 5.0 mmol) in dichloromethane (50 mL) at ambient temperature there is added DDQ (1.4 g, 6.0 mmol). The reaction mixture is stirred for 2 days and is then washed with saturated NaHCO 3 solution. The aqueous phase is extracted with ethyl acetate, the organic phase being washed with saturated NaCl solution, dried over MgSO 4 , filtered and concentrated under reduced pressure. The residue is purified by column chromatography (petroleum ether-ethyl acetate: 80-20) to yield the title product in solid form in a yield of 55%.

Method B:

To a solution of TCQ (615 mg, 2.5 mmol) in toluene (1.5 mL) heated to 80° C. there is added the compound obtained in Step C (462 mg, 2.3 mmol) dissolved in toluene (3.5 mL). The mixture is then refluxed for 2.5 hours and is then diluted with water and extracted with petroleum ether. The organic phase is washed with NaOH solution (30% by weight) and with water and is then dried over MgSO 4 , filtered and concentrated under reduced pressure. The residue is purified by column chromatography (petroleum ether-ethyl acetate: 80-20) to yield the title product in solid form in a yield of 61%.

HRMS (EI, m/z) Calc. for C 13 H 11 NO: 197.0841. found: 197.0838.

›Step E: N-[2-(7-Methoxy-1-naphthyl)ethyl]acetamide

The reaction was carried out on a larger batch in order to optimise the yield obtained: 136 g of Raney nickel, 2.06 L of ethanol and 0.23 L of water are introduced into an 8 L reactor. Whilst stirring at 70° C. and under 30 bars of hydrogen, the compound obtained in Step D (0.8 kg) dissolved in acetic anhydride (2.4 L) is slowly added. At the end of the addition, the reaction mixture is stirred for 1 hour under hydrogen at 30 bar, the reactor is then decompressed and the liquors are filtered. After concentration of the mixture, the residue is crystallised from a mixture of ethanol/water 35/65 to yield the title product in a yield of 89% and with a chemical purity greater than 99%.

Melting point: 108° C.

›EXAMPLE 2

N-[2-(7-ethoxy-1-naphthyl)ethyl]acetamide

›Step A: (7-Methoxy-1,2-dihydro-1-naphthyl)acetonitrile

A solution of allyl cyanide (6.75 mL, 84.0 mmol) and S-[2-(4-methoxyphenyl)-2-oxoethyl]-O-ethyl dithiocarbonate 1 (11.3 g, 42.0 mmol) in ethyl acetate (45 mL) is heated at reflux for 15 minutes under a nitrogen atmosphere. There is added, firstly, an amount of dilauroyl peroxide (10 mol %) to the solution under reflux. After 1 hour 30 minutes, another amount of dilauroyl peroxide (5 mol %) is also introduced. When the reagents have been completely consumed, the mixture is cooled to ambient temperature and concentrated under reduced pressure. The crude mixture is redissolved in chlorobenzene (640 mL) and the solution is refluxed for 15 minutes under a nitrogen atmosphere. Dilauroyl peroxide is then gradually added to the solution under reflux (10 mol % every 10 minutes). When the reaction is complete, the mixture is cooled to ambient temperature and concentrated under reduced pressure. Acetonitrile is then introduced in order to cause a large part of the dilauroyl peroxide compounds to precipitate out. The mixture is then filtered and concentrated under reduced pressure. Half the crude oil thereby obtained is redissolved in isopropanol (100 mL) at ambient temperature in the presence of aluminium isopropoxide (13.6 g, 66.6 mmol). The reaction mixture is refluxed. When the reagents have been completely consumed, a few crystals of p-toluenesulphonic acid monohydrate are added and a Dean-Stark apparatus is mounted on top of the flask. The mixture is again refluxed for 2 hours, during which the isopropanol is gradually replaced with toluene by means of the Dean-Stark apparatus. A 1N HCl solution is then added and the resulting phases are separated. The aqueous phase is extracted with ethyl acetate, the organic phases being washed with saturated NaHCO 3 solution and with saturated NaCl solution, then dried over MgSO 4 , filtered and concentrated under reduced pressure. The residue is purified by column chromatography (petroleum ether-ethyl acetate: 80-20) to yield the title product in the form of an oil in a yield of 24%.

HRMS (EI, m/z) Calc. for C 13 H 13 NO: 199.0997. found: 199.1001.

›Step B: (7-Methoxy-1-naphthyl)acetonitrile

The procedure is analogous to Step D of Example 1.

›Step C: N-[2-(7-Methoxy-1-naphthyl)ethyl]acetamide

The procedure is analogous to Step E of Example 1.

2 of 12 part labels are ours — the grant heads the rest

Claims

18 · 5 independent · depth 2
123456789101112131415161718
18 granted claims

Classifications

7 codes
IPC · International Patent Classification
Section C — Chemistry; metallurgy
  • C07C253/30
  • C07C231/02
  • C07C255/33
  • C07C233/18
  • C07C255/40
  • C07C255/37
  • C07C231/06

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

Pendency
4.9 y
1,791 days filing → grant
Office actions
1
non-final + final
Responses
2
no RCE
Examiner
Gary Kunz
art unit 3991 · TC 3900
Citations: 18 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Worldwide family

64 members · 45 offices
US3EP3JP2KR2CN2WO2AP2AR1AU2BR1CA2CL1CO1CR1CU2CY1DK1EA2EC1ES2FR2GE1HK1HR1HU1IL2JO1ME1MX1MY1NI1NZ1PE1PH1PL1RS2RU2SA1SG1SI1TN1TW2UA1UY1ZA1
this patentIP5 & PCTother officessolid = grantedhover for detail · click to open
Members
64
DOCDB simple family 44088993
Offices
45
US · EP · JP · KR · CN · WO
Granted
16 of 64
grant date present
Non-English titles
39
shown as filed, never translated
›IP5 & PCT — 14 members
OfficePublicationKindPublishedFiledStatusTitle
USUS-2013289307-A1A131 Oct 20134 Jan 2012publishedProcess for the synthesis of agomelatine
USUS-8853449-B2B27 Oct 20144 Jan 2012grantedProcess for the synthesis of agomelatine
USthis patentUS-RE46218-EE129 Nov 20164 Jan 2012grantedProcess for the synthesis of agomelatine
EPEP-2661422-A1A113 Nov 20134 Jan 2012publishedProcede et intermediaires de synthese de l ' agomelatinefr
EPEP-2661422-B1B120 Apr 20164 Jan 2012grantedProcédé et intermédiaires de synthèse de l'agomélatinefr
EPEP-2661422-B9B97 Sep 20164 Jan 2012grantedVerfahren und zwischenprodukte zur herstellung von agomelatinede
JPJP-2014509309-AA17 Apr 20144 Jan 2012publishedアゴメラチン合成のための方法及び中間体ja
JPJP-5837616-B2B224 Dec 20154 Jan 2012grantedアゴメラチン合成のための方法及び中間体ja
KRKR-20130115345-AA21 Oct 20134 Jan 2012publishedProcess and intermediates for synthesizing agomelatine
KRKR-101543432-B1B110 Aug 20154 Jan 2012grantedProcess and intermediates for synthesizing agomelatine
CNCN-103313965-AA18 Sep 20134 Jan 2012published合成阿戈美拉汀的方法和中间体zh
CNCN-103313965-BB5 Aug 20154 Jan 2012granted合成阿戈美拉汀的方法和中间体zh
WOWO-2012113999-A1A130 Aug 20124 Jan 2012publishedProcede et intermediaires de synthese de l ' agomelatinefr
WOWO-2012113999-A8A81 Aug 20134 Jan 2012publishedProcede et intermediaires de synthese de l ' agomelatinefr
›Other offices — 50 members
OfficePublicationKindPublishedFiledStatusTitle
APAP-2013007022-A0A031 Jul 20134 Jan 2012publishedNew process for the synthesis of agomelatine
APAP-3609-AA26 Feb 20164 Jan 2012grantedNew process for the synthesis of agomelatine
ARAR-084780-A1A126 Jun 20134 Jan 2012publishedProcedimiento de sintesis de la agomelatinaes
AUAU-2012220474-A1A111 Jul 20134 Jan 2012publishedProcess and intermediates for synthesizing agomelatine
AUAU-2012220474-B2B220 Aug 20154 Jan 2012grantedProcess and intermediates for synthesizing agomelatine
BRBR-112013017307-A2A24 Oct 20164 Jan 2012publishedprocesso de síntese da agomelatinapt
CACA-2823587-A1A130 Aug 20124 Jan 2012publishedProcede et intermediaires de synthese de l'agomelatinefr
CACA-2823587-CC24 Nov 20154 Jan 2012grantedProcede et intermediaires de synthese de l'agomelatinefr
CLCL-2013001882-A1A16 Dec 201325 Jun 2013publishedProcedimiento de sintesis industrial del compuesto de formula (i) agomelatina, a partir de cianuro de alilo; compuestos intermediarios.es
COCO-6731101-A2A215 Aug 20133 Jul 2013publishedNuevo procedimiento de síntesis de la agomelatinaes
CRCR-20130301-AA8 Aug 201319 Jun 2013publishedNuevo procedimiento de síntesis de la agomelatinaes
CUCU-20130092-A7A729 Aug 20134 Jan 2012publishedNuevo procedimiento para la síntesis de la agomelatinaes
CUCU-24289-B1B18 Dec 20174 Jan 2012publishedNuevo procedimiento para la síntesis de la agomelatinaes
CYCY-1117774-T1T117 May 201711 Jul 2016publishedΜεθοδος και ενδιαμεσα συνθεσης της αγομελατινηςel
DKDK-2661422-T3T324 Oct 20164 Jan 2012grantedMETHOD AND intermediates for the synthesis of agomelatine
EAEA-201300794-A1A128 Feb 20144 Jan 2012publishedНовый способ синтеза агомелатинаru
EAEA-022077-B1B130 Oct 20154 Jan 2012publishedNovel process for the synthesis of agomelatine
ECEC-SP13012735-AA30 Sep 20135 Jul 2013publishedNuevo procedimiento de síntesis de la agomelatinaes
ESES-2583682-T3T321 Sep 20164 Jan 2012grantedProcedimiento e intermedios de síntesis de agomelatinaes
ESES-2583682-T9T931 Oct 20164 Jan 2012publishedProcedimiento e intermedios de síntesis de agomelatinaes
FRFR-2970000-A1A16 Jul 20125 Jan 2011publishedNouveau procede de synthese de l'agomelatinefr
FRFR-2970000-B1B14 Jan 20135 Jan 2011grantedNouveau procede de synthese de l'agomelatinefr
GEGE-P20156365-BB10 Sep 20154 Jan 2012publishedNew method for agomelatine synthesizes and intermediates
HKHK-1189571-A1A113 Jun 20144 Jan 2012publishedProcess and intermediates for synthesizing agomelatine
HRHR-P20160713-T1T129 Jul 20164 Jan 2012publishedPostupak i intermedijarni proizvodi za pripravu agomelatinahr
HUHU-E028471-T2T228 Dec 20164 Jan 2012publishedEljárás és köztitermékek agomelatin elõállításárahu
ILIL-227281-A0A030 Sep 20131 Jul 2013publishedProcess and intermediates for synthesizing agomelatine
ILIL-227281-AA30 Jun 20151 Jul 2013publishedProcess and intermediates for synthesizing agomelatine
JOJO-3200-B1B18 Mar 201820 Dec 2011grantedطريقة ونواتج وسيطة لتحضير أجوميلاتينar
MEME-02408-BB20 Sep 20164 Jan 2012publishedVerfahren und zwischenprodukte zur synthese von agomelatinde
MXMX-2013007837-AA6 Sep 20134 Jan 2012publishedProcess and intermediates for synthesizing agomelatine.
MYMY-162977-AA31 Jul 20174 Jan 2012publishedProcess and intermediates for the synthesis of agomelatine
NINI-201300062-AA11 Dec 20133 Jul 2013publishedProcedimiento e intermedios de síntesis de la agomelatinaes
NZNZ-612173-AA28 Aug 20154 Jan 2012publishedProcess and intermediates for synthesizing agomelatine
PEPE-20140037-A1A11 Feb 20144 Jan 2012publishedNuevo procedimiento de sintesis de la agomelatinaes
PHPH-12013501278-A1A127 Mar 20154 Jan 2012publishedNew process for the synthesis of agomelatine
PLPL-2661422-T3T331 Oct 20164 Jan 2012publishedMethod and intermediate products for the preparation of agomelatine
RSRS-54753-B1B131 Oct 20164 Jan 2012publishedPostupak i intermedijerni proizvodi za sintezu agomelatinasr
RSRS-54753-B9B930 Sep 20194 Jan 2012publishedMethod and intermediate products for the preparation of agomelatine
RURU-2013136344-AA10 Feb 20154 Jan 2012publishedНовый способ синтеза агомелатинаru
RURU-2550812-C2C220 May 20154 Jan 2012grantedНовый способ синтеза агомелатинаru
SASA-112330134-B1B125 Aug 20143 Jan 2012publishedNew Process for the Synthesisof Agomelatine
SGSG-191733-A1A130 Aug 20134 Jan 2012publishedProcess and intermediates for synthesizing agomelatine
SISI-2661422-T1T131 Aug 20164 Jan 2012publishedMethod and intermediate products for the preparation of agomelatine
TNTN-2013000274-A1A110 Nov 201425 Jun 2013publishedProcede et intermediaires de synthese de l ' agomelatinefr
TWTW-201309623-AA1 Mar 20134 Jan 2012published阿戈美拉丁(agomelatine)之新穎合成方法zh
TWTW-I438180-BB21 May 20144 Jan 2012granted阿戈美拉丁(agomelatine)之新穎合成方法zh
UAUA-104122-C2C225 Dec 20131 Apr 2012publishedСпосіб синтезу агомелатинуuk
UYUY-33845-AA31 Jul 201230 Dec 2011publishedNuevo procedimiento de sintesis de la agomelatinaes
ZAZA-201305027-BB26 Mar 20144 Jul 2013publishedProcess and intermediates for synthesizing agomelatine

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock